Melissa Nelson

653 total citations
21 papers, 516 citations indexed

About

Melissa Nelson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Melissa Nelson has authored 21 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Melissa Nelson's work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (4 papers) and Folate and B Vitamins Research (4 papers). Melissa Nelson is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (4 papers) and Folate and B Vitamins Research (4 papers). Melissa Nelson collaborates with scholars based in United States. Melissa Nelson's co-authors include David M. Goldenberg, Frank H. DeLand, Christopher P. Leamon, Marilynn Vetzel, Joseph A. Reddy, Ryan Dorton, Sidney Bennett, Iontcho R. Vlahov, Paul J. Kleindl and F. James Primus and has published in prestigious journals such as Gastroenterology, Cancer and Cancer Research.

In The Last Decade

Melissa Nelson

21 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Nelson United States 11 208 197 185 63 55 21 516
Le-Cun Xu United States 8 172 0.8× 246 1.2× 226 1.2× 93 1.5× 42 0.8× 12 608
Shundong Ji China 13 149 0.7× 122 0.6× 227 1.2× 24 0.4× 60 1.1× 35 500
M.K. Tsoumpra Japan 9 83 0.4× 289 1.5× 314 1.7× 76 1.2× 27 0.5× 16 655
Xuchen Duan United States 8 95 0.5× 301 1.5× 229 1.2× 69 1.1× 19 0.3× 11 653
RHJ Begent United Kingdom 14 377 1.8× 131 0.7× 233 1.3× 46 0.7× 51 0.9× 18 564
Kelly Davis Orcutt United States 13 334 1.6× 155 0.8× 201 1.1× 23 0.4× 57 1.0× 25 510
Chunjing Yu China 13 298 1.4× 180 0.9× 127 0.7× 34 0.5× 28 0.5× 46 566
Julliëtte E M van Eerd Netherlands 10 317 1.5× 168 0.9× 113 0.6× 17 0.3× 25 0.5× 13 501
Mary‐Keara Boss United States 11 98 0.5× 161 0.8× 142 0.8× 22 0.3× 66 1.2× 41 616
Maria Kissel Germany 9 80 0.4× 72 0.4× 166 0.9× 33 0.5× 15 0.3× 13 408

Countries citing papers authored by Melissa Nelson

Since Specialization
Citations

This map shows the geographic impact of Melissa Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Nelson more than expected).

Fields of papers citing papers by Melissa Nelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Nelson. The network helps show where Melissa Nelson may publish in the future.

Co-authorship network of co-authors of Melissa Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Nelson. A scholar is included among the top collaborators of Melissa Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Nelson. Melissa Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, Joseph A., Melissa Nelson, Marilynn Vetzel, et al.. (2020). Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent. Scientific Reports. 10(1). 12772–12772. 8 indexed citations
2.
Lu, Yingjuan, Haiyan Chu, Leroy W. Wheeler, et al.. (2019). Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies. Frontiers in Oncology. 9. 151–151. 46 indexed citations
3.
Chu, Haiyan, Jonathan M. Shillingford, Joseph A. Reddy, et al.. (2019). Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys. Molecular Pharmaceutics. 16(9). 3985–3995. 6 indexed citations
4.
Leamon, Christopher P., Joseph A. Reddy, Ryan Dorton, et al.. (2019). Prostate-Specific Membrane Antigen-Specific Antitumor Activity of a Self-Immolative Tubulysin Conjugate. Bioconjugate Chemistry. 30(6). 1805–1813. 27 indexed citations
5.
Reddy, Joseph A., Ryan Dorton, Melissa Nelson, et al.. (2018). Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic. Scientific Reports. 8(1). 8943–8943. 33 indexed citations
6.
Reddy, Joseph A., et al.. (2017). Abstract 2133: Pre-clinical studies of EC2629, a highly potent FR targeted DNA crosslinking agent. Cancer Research. 77(13_Supplement). 2133–2133. 1 indexed citations
7.
Vlahov, Iontcho R., Paul J. Kleindl, Hari Krishna R. Santhapuram, et al.. (2017). Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates. Bioconjugate Chemistry. 28(12). 2921–2931. 10 indexed citations
8.
Guertin, Amy D., Jennifer O’Neil, Alexander Stoeck, et al.. (2016). High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide. Molecular Cancer Therapeutics. 15(8). 1998–2008. 16 indexed citations
9.
Nelson, Melissa, et al.. (2016). Development and validation of a UPLC–MS/MS method for the novel folate-targeted small molecule drug conjugate EC1456 and its metabolites in tumor homogenates from mice. Journal of Pharmaceutical and Biomedical Analysis. 122. 148–156. 4 indexed citations
10.
Reddy, Joseph A., et al.. (2015). Abstract 5359: Antitumor efficacy of EC1456 in patient derived xenograft models of ovarian, endometrial, NSCLC and TNBC. Cancer Research. 75(15_Supplement). 5359–5359. 1 indexed citations
11.
Leamon, Christopher P., Iontcho R. Vlahov, Joseph A. Reddy, et al.. (2014). Folate–Vinca Alkaloid Conjugates for Cancer Therapy: A Structure–Activity Relationship. Bioconjugate Chemistry. 25(3). 560–568. 54 indexed citations
12.
Reddy, Joseph A., et al.. (2014). Abstract 832: Pre-clinical development of EC1456: A potent Folate targeted Tubulysin SMDC. Cancer Research. 74(19_Supplement). 832–832. 7 indexed citations
13.
Reddy, Joseph A., et al.. (2014). Rational Combination Therapy of Vintafolide (EC145) with Commonly Used Chemotherapeutic Drugs. Clinical Cancer Research. 20(8). 2104–2114. 23 indexed citations
14.
Leamon, Christopher P., Joseph A. Reddy, Ryan Dorton, et al.. (2012). Abstract 3622: Predicting response to EC145 therapy using the folate receptor-specific radiodiagnostic imaging agent, 99mTc-EC20. Cancer Research. 72(8_Supplement). 3622–3622. 2 indexed citations
15.
Reddy, Joseph A., et al.. (2011). Abstract 2570: Combination studies of EC145 with approved anti-cancer drugs for ovarian cancer. Cancer Research. 71(8_Supplement). 2570–2570. 1 indexed citations
16.
Leamon, Christopher P., Joseph A. Reddy, Patrick Klein, et al.. (2010). Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications. Journal of Pharmacology and Experimental Therapeutics. 336(2). 336–343. 41 indexed citations
17.
Rooney, Michael W., William Pfister, Mary C. Mahoney, et al.. (2008). Long-Term, Multicenter Study of the Safety and Efficacy of Topical Alprostadil Cream in Male Patients with Erectile Dysfunction. The Journal of Sexual Medicine. 6(2). 520–534. 32 indexed citations
18.
Goldenberg, David M., et al.. (1983). Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. Gastroenterology. 84(3). 524–532. 91 indexed citations
19.
Shochat, Dan, et al.. (1982). Colon-specific antigen-p (CSAp). I: Initial clinical evaluation as a marker for colorectal cancer. Cancer. 50(5). 919–926. 9 indexed citations
20.
Goldenberg, David M., Frank H. DeLand, Ellen N. Spremulli, et al.. (1980). Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer. 45(10). 2500–2505. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026